Sakoff, Jennette A., Howitt, Ian J., Ackland, Stephen P., McCluskey, Adam. Springer-Verlag; 2004. Serine/threonine protein phosphatase inhibition enhances the effect of thymidylate synthase inhibition.

McLachlan, Sue-Anne, Fisher, Richard J., MacKay, John, Ngan, Samuel Y., Zalcberg, John, Solomon, Michael, Burmeister, Bryan, Goldstein, David, Leong, Trevor, Ackland, Stephen P., McKendrick, Joseph, McClure, Bev. Elsevier; 2016. The impact on health-related quality of life in the first 12 months: a randomised comparison of preoperative short-course radiation versus long-course chemoradiation for T3 rectal cancer (Trans-Tasman Radiation Oncology Group Trial 01.04).

Ngan, Samuel Y., Burmeister, Bryan, McKendrick, Joseph, Leong, Trevor, Hartopeanu, Cris, Zalcberg, John, Mackay, John, Fisher, Richard J., Solomon, Michael, Goldstein, David, Joseph, David, Ackland, Stephen P., Schache, David, McClure, Bev, McLachlan, Sue-Anne. American Society of Clinical Oncology; 2012. Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group Trial 01.04.

McCluskey, Adam, Walkom, Cecilia, Bowyer, Michael C., Ackland, Stephen P., Gardiner, Emma, Sakoff, Jennette A.. Elsevier Science; 2001. Cantharimides: a new class of modified cantharidin analogues inhibiting protein phosphatases 1 and 2A.

Ackland, Stephen P., Bull, James M., Boyle, Frances M.. Wiley-Blackwell Publishing; 2009. Nab-paclitaxel: a bright new SPARC in taxane therapy of cancer (editorial).

Ackland, Stephen P., Gebski, V., Forbes, J. F., Coates, A. S., , Zdenkowski, N., Wilson, A., Green, M., Tees, S., Dhillon, H., Van Hazel, G., Levi, J., Simes, R. J.. Springer; 2019. Dose intensity in anthracycline-based chemotherapy for metastatic breast cancer: mature results of the randomised clinical trial ANZ 9311.

Fradgley, Elizabeth A., Paul, Christine L., Bryant, Jamie, Collins, Nicolas, Ackland, Stephen P., Bellamy, Douglas, Levi, Christopher R.. Sage; 2016. Collaborative patient-centered quality improvement: a cross-sectional survey comparing the types and numbers of quality initiatives selected by patients and health professionals.

Stewart, Scott G., Hill, Timothy A., Gilbert, Jayne, Ackland, Stephen P., Sakoff, Jennette A., McCluskey, Adam. Pergamon; 2007. Synthesis and biological evaluation of norcantharidin analogues: towards PP1 selectivity.

Tebbutt, Niall C., Wilson, Kate, Forgeson, Garry, Cunningham, David, Saunders, Mark P., Stockler, Martin R., Chua, Yujo, Zalcberg, John R., Simes, R. John, Price, Timothy J., Gebski, Val J., Cummins, Michelle M., Zannino, Dianna, van Hazel, Guy A., Robinson, Bridget, Broad, Adam, Ganju, Vinod, Ackland, Stephen P.. American Society of Clinical Oncology; 2010. Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: results of the Australasian Gastrointestinal Trials Group Randomized Phase III MAX Study.

Bryant, Jamie, Sanson-Fisher, Rob, Fradgley, Elizabeth, Regan, Timothy, Hobden, Breanne, Ackland, Stephen P.. BioMed Central; 2015. Oncology patients overwhelmingly support tissue banking.

Garg, Madhu B., Ackland, Stephen P.. Springer; 2011. Pyridoxine to protect from oxaliplatin-induced neurotoxicity without compromising antitumour effect.

Hill, Timothy A., Stewart, Scott G., Sauer, Benjamin, Gilbert, Jayne, Ackland, Stephen P., Sakoff, Jennette A., McCluskey, Adam. Pergamon; 2007. Heterocyclic substituted cantharidin and norcantharidin analogues-synthesis, protein phosphatase (1 and 2A) inhibition, and anti-cancer activity.

Hill, Timothy A., Stewart, Scott G., Gordon, Christopher P., Ackland, Stephen P., Gilbert, Jayne, Sauer, Benjamin, Sakoff, Jennette A., McCluskey, Adam. Wiley; 2008. Norcantharidin analogues: synthesis, anticancer activity and protein phosphatase 1 and 2A inhibition.

Goldstein, David, Gainford, M Corona, Miller, Danielle, Shannon, Jenny, Brown, Chris, Tebbutt, Niall, Ackland, Stephen P., van Hazel, Guy, Jefford, Michael, Abdi, Ehtesham, Selva-Nayagam, Sid, Gebski, Val. Springer; 2011. Fixed-dose-rate gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas.

Wong, Mark, Balleine, Rosemary L., Hoskins, Janelle M., Mann, Graham J., Clarke, Christine L., Gurney, Howard, Blair, Elaine Y. L., McLachlan, Andrew J., Ackland, Stephen P., Garg, Madhu B., Evans, Scott, Farlow, David, Collins, Michael, Rivory, Laurent P.. American Society of Clinical Oncology; 2006. Predictors of vinorelbine pharmacokinetics and pharmacodynamics in patients with cancer.

McCluskey, Adam, Ackland, Stephen P., Bowyer, Michael C., Baldwin, Monique L., Garner, James, Walkom, Cecilia C., Sakoff, Jennette A.. Academic Press; 2003. Cantharidin analogues: synthesis and evaluation of growth inhibition in a panel of selected tumour cell lines.

Garg, Madhu B., Sakoff, Jennette A., Ackland, Stephen P.. Elsevier; 2011. A simple HPLC method for plasma level monitoring of mitotane and its two main metabolites in adrenocortical cancer patients.

Hill, Timothy A., Stewart, Scott G., Ackland, Stephen P., Gilbert, Jayne, Sauer, Benjamin, Sakoff, Jennette A., McCluskey, Adam. Pergamon; 2007. Norcantharimides, synthesis and anticancer activity: synthesis of new norcantharidin analogues and their anticancer evaluation.

Price, Timothy J., Segelov, Eva, Shapiro, Jeremy D., Burge, Matthew, Haller, Daniel G., Ackland, Stephen P., Tebbutt, Niall C., Karapetis, Christos S., Pavlakis, Nick, Sobrero, Alberto F., Cunningham, David. Expert Reviews; 2013. Current opinion on optimal treatment for colorectal cancer.

Stockler, Martin R., Harvey, Vernon J., Gainford, M. Corona, Fong, Akiko, Paksec, Lisa, Sourjina, Tatiana, Zannino, Diana, Gebski, Val, Simes, R. John, Forbes, John F., Coates, Alan S., Francis, Prudence A., Byrne, Michael J., Ackland, Stephen P., Fitzharris, Bernie, Van Hazel , Guy, Wilcken, Nicholas R. C., Grimison, Peter S., Nowak, Anna K.. American Society of Clinical Oncology; 2011. Capecitabine versus classical cyclophosphamide, methotrexate, and fluorouracil as first-line chemotherapy for advanced breast cancer.

Le Teuff, Gwénaël, Cozic, Nathalie, Largiadèr, Carlo R., Marinaki, Anthony, Jennings, Barbara A., Wettergren, Yvonne, Di Paolo, Antonello, Gross, Eva, Budai, Barna, Ackland, Stephen P., van Kuilenburg, André B. P., Mcleod, Howard L., Boyer, Jean-Christophe, Milano, Gérard, Thomas, F, Loriot, M-A, Kerr, D, Schellens, JHM, Laurent-Puig, P, Shi, Q, Pignon, J-P, Etienne-Grimaldi, M-C, Boige, Valérie, Diasio, Robert b., Taieb, Julien, Meulendijks, Didier, Palles, Claire, Schwab, Matthias, Deenen, Maarten. Nature Publishing Group; 2024. Dihydropyrimidine dehydrogenase gene variants for predicting grade 4-5 fluoropyrimidine-induced toxicity: FUSAFE individual patient data meta-analysis.